Start for free

Metropolis Healthcare Limited

NSE: METROPOLISHealthcare

Metropolis Healthcare Limited Share Price & Analysis

₹588.70−0.54%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹588.70−0.54%
Open
₹589.80
High
₹591.80
Low
₹585.50
Close
₹588.70
52W High
₹609.05
52W Low
₹412.00
Volume
239K
Lot Size
1
Sector
Healthcare
Market Cap
₹12K Cr
Face Value
₹2
Mid Cap

Price Chart

Candle
Range

Fundamentals

P/E
58.60
Sector P/E
54.70
P/B
7.76
EPS
₹9.73
ROE
13.60%
ROCE
17.80%
D/E Ratio
0.15
Div Yield
0.34%
Book Value
₹73.00

Strengths

  • Efficient capital deployment (ROCE 17.8%)
  • Low debt relative to equity (D/E 0.2x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    METROPOLIS · as of Mar 2026

    Promoters48.89%0.51pp
    FII15.29%1.44pp
    DII30.30%0.30pp
    Public5.51%1.65pp
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters49.74%49.67%49.62%49.43%49.40%48.89%
    FII21.66%18.90%18.25%18.56%16.73%15.29%
    DII20.73%24.86%27.42%28.02%30.00%30.30%
    Public7.87%6.57%4.69%3.98%3.86%5.51%

    Corporate Events

    To consider and approve the financial results for the period ended Jun 30, 2026

    Results3 Aug 2026

    Interim Dividend - Re 1 Per Share

    Dividend18 May 2026

    To consider and approve the audited financial results of the company for the quarter and financial year ended March 31, 2026 and dividend

    Dividend12 May 2026

    Bonus 3:1

    Bonus19 Mar 2026

    Interim Dividend - Rs 4 Per Share

    Dividend10 Nov 2025

    Interim Dividend - Rs 4 Per Share

    Dividend16 Nov 2023

    Annual General Meeting

    AGM9 Aug 2023

    Latest News

    All news

    Metropolis Healthcare hosts investor call with no major announcements.

    *Metropolis Healthcare hosts investor call with no major announcements.* The company conducted an analyst and institutional investor meet, sharing operational updates without revealing significant new developments. Transcript available via NSE corporate filing. No changes to guidance or business outlook were communicated. 📊 *STOCKS:* METROPOLIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorCall

    NSE Filing10 Aug
    Low Impact

    Metropolis Healthcare hosts investor meet, shares updates

    *Metropolis Healthcare hosts investor meet, shares updates.* The company provided insights during its recent analyst and institutional investor call. No major financial announcements or guidance changes were disclosed. The recording of the session is available for review. 📊 *STOCKS:* METROPOLIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorMeet

    NSE Filing5 Aug
    Low Impact

    Metropolis Healthcare publishes statutory newspaper notice

    *Metropolis Healthcare publishes statutory newspaper notice.* This is a routine compliance requirement and does not indicate any operational or financial change. **No material financial figures** or strategic updates were disclosed. Such filings are standard practice for listed companies. 📊 *STOCKS:* $METROPOLIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #StatutoryFiling

    NSE Filing5 Aug
    Low Impact

    Metropolis Healthcare publishes mandatory newspaper notice

    *Metropolis Healthcare publishes mandatory newspaper notice.* This is a routine regulatory disclosure filed with the NSE, typically related to board meetings or shareholder notices. No **financial figures** or strategic updates were disclosed. The move complies with SEBI’s listing norms. 📊 *STOCKS:* METROPOLIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling

    NSE Filing28 Jul
    Low Impact

    Metropolis Healthcare allots 36,900 stock units

    *Metropolis Healthcare allots 36,900 equity shares under its 2020 stock unit plan.* The allotment is part of the company's restricted stock unit scheme. This move supports employee retention and performance incentives. No immediate financial impact is expected. 📊 *STOCKS:* METROPOLIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #StockUnits

    NSE Filing9 Jul
    Low Impact

    Financials

    Quarterly Results

    MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Revenue
    ₹406 Cr
    5.4%
    ₹429 Cr
    11.1%
    ₹386 Cr
    11.9%
    ₹345 Cr
    6.8%
    ₹323 Cr
    7.7%
    ₹350 Cr
    11.8%
    ₹313 Cr
    5.4%
    ₹331 Cr
    Op. Profit
    ₹95 Cr
    12.0%
    ₹108 Cr
    20.0%
    ₹90 Cr
    45.2%
    ₹62 Cr
    13.9%
    ₹72 Cr
    20.0%
    ₹90 Cr
    13.9%
    ₹79 Cr
    1.3%
    ₹80 Cr
    OPM
    23.0%
    8.0%
    25.0%
    8.7%
    23.0%
    27.8%
    18.0%
    18.2%
    22.0%
    15.4%
    26.0%
    4.0%
    25.0%
    4.2%
    24.0%
    Net Profit
    ₹42 Cr
    20.8%
    ₹53 Cr
    17.8%
    ₹45 Cr
    55.2%
    ₹29 Cr
    6.5%
    ₹31 Cr
    34.0%
    ₹47 Cr
    23.7%
    ₹38 Cr
    2.7%
    ₹37 Cr
    EPS (₹)
    2
    21.3%
    2.54
    17.1%
    2.17
    53.9%
    1.41
    7.8%
    1.53
    32.6%
    2.27
    22.7%
    1.85
    3.9%
    1.78

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹1.6K Cr
    23.7%
    ₹1.3K Cr
    10.2%
    ₹1.2K Cr
    5.2%
    ₹1.1K Cr
    6.5%
    ₹1.2K Cr
    23.0%
    ₹998 Cr
    16.6%
    ₹856 Cr
    12.5%
    ₹761 Cr
    17.6%
    ₹647 Cr
    18.7%
    ₹545 Cr
    Expenses
    ₹1.2K Cr
    21.2%
    ₹1.0K Cr
    11.2%
    ₹920 Cr
    7.6%
    ₹855 Cr
    2.8%
    ₹880 Cr
    24.3%
    ₹708 Cr
    14.4%
    ₹619 Cr
    10.7%
    ₹559 Cr
    19.7%
    ₹467 Cr
    15.3%
    ₹405 Cr
    Op. Profit
    ₹406 Cr
    31.8%
    ₹308 Cr
    6.9%
    ₹288 Cr
    1.7%
    ₹293 Cr
    15.8%
    ₹348 Cr
    20.0%
    ₹290 Cr
    22.4%
    ₹237 Cr
    16.7%
    ₹203 Cr
    12.2%
    ₹181 Cr
    29.3%
    ₹140 Cr
    OPM
    25.0%
    8.7%
    23.0%
    4.2%
    24.0%
    7.7%
    26.0%
    7.1%
    28.0%
    3.4%
    29.0%
    3.6%
    28.0%
    3.7%
    27.0%
    3.6%
    28.0%
    7.7%
    26.0%
    Other Income
    ₹16 Cr
    6.7%
    ₹15 Cr
    66.7%
    ₹9 Cr
    40.0%
    ₹15 Cr
    55.9%
    ₹34 Cr
    183.3%
    ₹12 Cr
    170.6%
    ₹-17 Cr
    312.5%
    ₹8 Cr
    33.3%
    ₹6 Cr
    84.6%
    ₹39 Cr
    Interest
    ₹29 Cr
    20.8%
    ₹24 Cr
    14.3%
    ₹28 Cr
    12.5%
    ₹32 Cr
    28.0%
    ₹25 Cr
    108.3%
    ₹12 Cr
    7.7%
    ₹13 Cr
    225.0%
    ₹4 Cr
    0.0%
    ₹4 Cr
    100.0%
    ₹2 Cr
    Depreciation
    ₹134 Cr
    22.9%
    ₹109 Cr
    16.0%
    ₹94 Cr
    5.6%
    ₹89 Cr
    41.3%
    ₹63 Cr
    37.0%
    ₹46 Cr
    17.9%
    ₹39 Cr
    95.0%
    ₹20 Cr
    5.3%
    ₹19 Cr
    11.8%
    ₹17 Cr
    PBT
    ₹259 Cr
    35.6%
    ₹191 Cr
    9.1%
    ₹175 Cr
    6.9%
    ₹188 Cr
    35.8%
    ₹293 Cr
    20.1%
    ₹244 Cr
    44.4%
    ₹169 Cr
    9.6%
    ₹187 Cr
    14.0%
    ₹164 Cr
    2.5%
    ₹160 Cr
    Tax %
    26.0%
    8.3%
    24.0%
    7.7%
    26.0%
    8.3%
    24.0%
    11.1%
    27.0%
    8.0%
    25.0%
    4.2%
    24.0%
    29.4%
    34.0%
    6.3%
    32.0%
    3.0%
    33.0%
    Net Profit
    ₹191 Cr
    30.8%
    ₹146 Cr
    14.1%
    ₹128 Cr
    10.5%
    ₹143 Cr
    33.5%
    ₹215 Cr
    17.5%
    ₹183 Cr
    43.0%
    ₹128 Cr
    3.2%
    ₹124 Cr
    10.7%
    ₹112 Cr
    4.7%
    ₹107 Cr
    EPS (₹)
    9.17
    31.0%
    7
    12.2%
    6.24
    10.6%
    6.98
    33.3%
    10.46
    16.9%
    8.95
    42.3%
    6.29
    5.0%
    5.99
    78.1%
    27.29
    2.6%
    26.61
    Div Payout
    55.0%
    0.0%
    100.0%
    16.0%
    44.8%
    29.0%
    52.6%
    19.0%
    13.6%
    22.0%
    31.3%
    32.0%
    41.8%
    55.0%
    0.0%
    100.0%
    49.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    0.0%
    ₹10 Cr
    Reserves
    ₹1.4K Cr
    7.6%
    ₹1.3K Cr
    21.6%
    ₹1.1K Cr
    11.0%
    ₹978 Cr
    11.6%
    ₹876 Cr
    25.9%
    ₹696 Cr
    35.7%
    ₹513 Cr
    25.7%
    ₹408 Cr
    0.7%
    ₹405 Cr
    29.0%
    ₹314 Cr
    Borrowings
    ₹201 Cr
    1.5%
    ₹204 Cr
    3.6%
    ₹197 Cr
    25.9%
    ₹266 Cr
    29.8%
    ₹379 Cr
    238.4%
    ₹112 Cr
    67.2%
    ₹67 Cr
    272.2%
    ₹18 Cr
    1700.0%
    ₹1 Cr
    0.0%
    ₹1 Cr
    Other Liabilities
    ₹359 Cr
    10.8%
    ₹324 Cr
    27.6%
    ₹254 Cr
    5.8%
    ₹240 Cr
    6.3%
    ₹256 Cr
    41.4%
    ₹181 Cr
    13.1%
    ₹160 Cr
    41.6%
    ₹113 Cr
    2.7%
    ₹110 Cr
    41.5%
    ₹188 Cr
    Total Liabilities
    ₹2.0K Cr
    7.2%
    ₹1.9K Cr
    20.2%
    ₹1.5K Cr
    3.5%
    ₹1.5K Cr
    1.7%
    ₹1.5K Cr
    52.1%
    ₹1.0K Cr
    33.3%
    ₹750 Cr
    36.4%
    ₹550 Cr
    4.6%
    ₹526 Cr
    2.7%
    ₹512 Cr
    Assets
    Fixed Assets
    ₹1.6K Cr
    8.7%
    ₹1.4K Cr
    22.9%
    ₹1.2K Cr
    5.0%
    ₹1.1K Cr
    5.9%
    ₹1.1K Cr
    208.7%
    ₹343 Cr
    15.9%
    ₹296 Cr
    39.0%
    ₹213 Cr
    2.9%
    ₹207 Cr
    2.5%
    ₹202 Cr
    CWIP
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹20 Cr
    233.3%
    ₹6 Cr
    ₹0 Cr
    100.0%
    ₹3 Cr
    50.0%
    ₹6 Cr
    ₹0 Cr
    100.0%
    ₹1 Cr
    Investments
    ₹21 Cr
    70.4%
    ₹71 Cr
    29.1%
    ₹55 Cr
    266.7%
    ₹15 Cr
    6.3%
    ₹16 Cr
    60.0%
    ₹10 Cr
    28.6%
    ₹14 Cr
    57.6%
    ₹33 Cr
    67.6%
    ₹102 Cr
    28.2%
    ₹142 Cr
    Other Assets
    ₹399 Cr
    17.0%
    ₹341 Cr
    7.9%
    ₹316 Cr
    7.1%
    ₹340 Cr
    22.7%
    ₹440 Cr
    32.0%
    ₹647 Cr
    48.1%
    ₹437 Cr
    46.6%
    ₹298 Cr
    38.0%
    ₹216 Cr
    29.3%
    ₹167 Cr
    Total Assets
    ₹2.0K Cr
    7.2%
    ₹1.9K Cr
    20.2%
    ₹1.5K Cr
    3.5%
    ₹1.5K Cr
    1.7%
    ₹1.5K Cr
    52.1%
    ₹1.0K Cr
    33.3%
    ₹750 Cr
    36.4%
    ₹550 Cr
    4.6%
    ₹526 Cr
    2.7%
    ₹512 Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
    Operating CF
    ₹263 Cr
    0.4%
    ₹264 Cr
    6.9%
    ₹247 Cr
    2.4%
    ₹253 Cr
    1.6%
    ₹249 Cr
    15.8%
    ₹215 Cr
    138.9%
    ₹90 Cr
    13.5%
    ₹104 Cr
    2.0%
    ₹102 Cr
    12.1%
    ₹91 Cr
    Investing CF
    ₹-199 Cr
    123.6%
    ₹-89 Cr
    285.4%
    ₹48 Cr
    106.5%
    ₹-736 Cr
    1268.3%
    ₹63 Cr
    160.6%
    ₹-104 Cr
    388.9%
    ₹36 Cr
    3500.0%
    ₹1 Cr
    101.2%
    ₹-86 Cr
    189.6%
    ₹96 Cr
    Financing CF
    ₹-87 Cr
    51.9%
    ₹-181 Cr
    38.0%
    ₹-292 Cr
    279.1%
    ₹163 Cr
    593.9%
    ₹-33 Cr
    40.0%
    ₹-55 Cr
    53.4%
    ₹-118 Cr
    35.6%
    ₹-87 Cr
    411.8%
    ₹-17 Cr
    90.2%
    ₹-174 Cr
    Net Cash Flow
    ₹-23 Cr
    283.3%
    ₹-6 Cr
    300.0%
    ₹3 Cr
    100.9%
    ₹-321 Cr
    215.1%
    ₹279 Cr
    398.2%
    ₹56 Cr
    600.0%
    ₹8 Cr
    55.6%
    ₹18 Cr
    1900.0%
    ₹-1 Cr
    107.1%
    ₹14 Cr
    Free Cash Flow
    ₹196 Cr
    2.0%
    ₹200 Cr
    2.6%
    ₹195 Cr
    12.6%
    ₹223 Cr
    0.9%
    ₹221 Cr
    23.5%
    ₹179 Cr
    167.2%
    ₹67 Cr
    25.6%
    ₹90 Cr
    100.0%
    ₹45 Cr
    43.0%
    ₹79 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
    Debtor Days
    41d
    7.9%
    38d
    2.6%
    39d
    2.5%
    40d
    11.1%
    45d
    18.2%
    55d
    16.7%
    66d
    15.8%
    57d
    5.6%
    54d
    0.0%
    54d
    Inventory Days
    65d
    12.1%
    58d
    9.4%
    64d
    5.9%
    68d
    15.3%
    59d
    34.1%
    44d
    20.0%
    55d
    3.8%
    53d
    39.5%
    38d
    17.4%
    46d
    Days Payable
    171d
    14.0%
    150d
    10.3%
    136d
    0.0%
    136d
    15.0%
    160d
    5.3%
    152d
    68.9%
    90d
    2.3%
    88d
    9.3%
    97d
    1.0%
    96d
    Cash Conv. Cycle
    -65d
    22.6%
    -53d
    60.6%
    -33d
    13.8%
    -29d
    48.2%
    -56d
    3.7%
    -54d
    280.0%
    30d
    42.9%
    21d
    520.0%
    -5d
    266.7%
    3d
    Working Capital Days
    -18d
    12.5%
    -16d
    27.3%
    -22d
    15.4%
    -26d
    188.9%
    -9d
    550.0%
    2d
    93.9%
    33d
    17.9%
    28d
    203.7%
    -27d
    437.5%
    8d
    ROCE
    15.0%
    6.3%
    16.0%
    5.9%
    17.0%
    41.4%
    29.0%
    19.4%
    36.0%
    10.0%
    40.0%
    7.0%
    43.0%
    0.0%
    43.0%
    6.5%
    46.0%
    35.3%
    34.0%

    Source: Screener.in · Lower days = better efficiency

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Metropolis Healthcare Limited share price today?
    Metropolis Healthcare Limited (METROPOLIS) is currently trading at ₹588.7 on NSE, down 0.54% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Metropolis Healthcare Limited available in F&O (Futures & Options)?
    Yes, Metropolis Healthcare Limited (METROPOLIS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Metropolis Healthcare Limited 52-week high and low?
    Metropolis Healthcare Limited's 52-week high is ₹609.05 and the 52-week low is ₹412. The current price of ₹588.7 is 3.3% below the 52W high.
    What is Metropolis Healthcare Limited P/E ratio?
    Metropolis Healthcare Limited's current P/E ratio is 58.6. This indicates the market is paying ₹58.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Metropolis Healthcare Limited options?
    Metropolis Healthcare Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade METROPOLIS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.